# Probiotic Lactobacillus GG to Eliminate VRE Colonization

> **NCT00756262** · PHASE1 · TERMINATED · sponsor: **Tufts Medical Center** · enrollment: 11 (actual)

## Conditions studied

- Vancomycin Resistant Enterococcal Colonization

## Interventions

- **BIOLOGICAL:** Lactobacillus GG or Culturelle

## Key facts

- **NCT ID:** NCT00756262
- **Lead sponsor:** Tufts Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-03
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Insufficient recruitment, no additional funding available
- **Last updated:** 2024-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00756262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00756262, "Probiotic Lactobacillus GG to Eliminate VRE Colonization". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00756262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*